A Population Pharmacokinetic and Pharmacodynamic Analysis of RP5063 Phase 2 Study Data in Patients with Schizophrenia or Schizoaffective Disorder
2018 · European Journal of Drug Metabolism and Pharmacokinetics · 5 citations
https://doi.org/10.1007/s13318-018-0472-z